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It has been well established that serotonin (5-HT) plays an important role in the striatum.
For example, during levodopa therapy for Parkinson’s disease (PD), the serotonergic
projections from the dorsal raphe nucleus (DRN) release dopamine as a false transmitter,
and there are strong indications that this pulsatile release is connected to dyskinesias
that reduce the effectiveness of the therapy. Here we present hypotheses about the
functional role of 5-HT in the normal striatum and present computational studies showing
the feasibility of these hypotheses. Dopaminergic projections to the striatum inhibit the
medium spiny neurons (MSN) in the striatopalladal (indirect) pathway and excite MSNs in
the striatonigral (direct) pathway. It has long been hypothesized that the effect of dopamine
(DA) depletion caused by the loss of SNc cells in PD is to change the “balance” between
the pathways to favor the indirect pathway. Originally, “balance” was understood to mean
equal firing rates, but now it is understood that the level of DA affects the patterns of
firing in the two pathways too. There are dense 5-HT projections to the striatum from
the dorsal raphe nucleus and it is known that increased 5-HT in the striatum facilitates
DA release from DA terminals. The direct pathway excites various cortical nuclei and
some of these nuclei send inhibitory projections to the DRN. Our hypothesis is that this
feedback circuit from the striatum to the cortex to the DRN to the striatum serves to
stabilize the balance between the direct and indirect pathways, and this is confirmed
by our model calculations. Our calculations also show that this circuit contributes to
the stability of the dopamine concentration in the striatum as SNc cells die during
Parkinson’s disease progression (until late phase). There may be situations in which there
are physiological reasons to “unbalance” the direct and indirect pathways, and we show
that projections to the DRN from the cortex or other brain regions could accomplish
this task.
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INTRODUCTION
The serotonergic system projects widely in the brain with tar-
gets including sensory, motor, and limbic systems (Feldman et al.,
1997; Hornung, 2003), and it participates in many neural func-
tions including cognition, mood, regulation of feeding, and sleep-
wake behavior (Feldman et al., 1997; Monti, 2011). The dorsal
raphe nucleus (DRN) contains a significant proportion of the
brain’s serotonergic neurons, and these axons are distinguished
from other serotonergic projections by their small varicosities
and their lack of true synapses, so that they contribute to vol-
ume transmission (Hornung, 2003). The result may be complex
modulation of neural activity rather than directly stimulating a
specific response, which may account for the fact that the effects
of these projections have been long debated; see for example
Monti (2010).
The DRN makes dense serotonergic projections to the basal
ganglia (BG), including the substantia nigra pars compacta (SNc)
and the striatum (Vertes, 1991).While the role of this serotonergic
innervation is unclear in healthy individuals, in the past 10 years,
it has become appreciated that these serotonergic projections
to the striatum play a special role in patients with Parkinson’s
disease (PD) being treated with levodopa (L-DOPA). In seroton-
ergic neurons, 5-Hydroxy-L-tryptophan is converted to serotonin
(5-HT) by amino acid decarboxylase, the same enzyme that con-
verts L-DOPA to dopamine (DA) in dopaminergic cells. Thus,
when L-DOPA is systemically administered, as is the common
first treatment for PD, serotonergic cells are also able to convert
the L-DOPA into DA, store it with 5-HT in the neuronal vesicles,
and then release a mixture of 5-HT and DA in response to action
potentials (Carta et al., 2007). In the striatum, the implication
is that cells are releasing DA without the restraint and homeo-
static mechanisms present on DA cells, allowing large fluctuations
in the level of extracellular DA in the striatum. When a minor-
ity of DA cells have been lost (to PD), the remaining cells may
be able to help regulate these fluctuations. But as more DA cells
die, these fluctuations are less restrained and dyskinesias occur
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(de la Fuente-Fernandez et al., 2001; Lindgren et al., 2010). These
effects were investigated using amathematical model in Reed et al.
(2012).
In this paper, we present a hypothesis about the role of 5-HT in
the healthy basal ganglia, focusing on the effects of 5-HT on the
so-called direct and indirect pathways. In the next two sections
we describe the direct and indirect pathways and our hypoth-
esis. In the following section, we will present a computational
model that we use to test the plausibility of our hypothesis. We
will then describe the results of computational experiments on the
model.
DIRECT AND INDIRECT PATHWAYS AND BALANCE
The BG are a group of subcortical nuclei including the stria-
tum, subthalamic nucleus, internal and external globus pallidus,
and substantia nigra. Cortical-BG-thalamic circuits are critically
involved in many functions including sensorimotor, emotion,
and cognition (Haber and Calzavara, 2009; Lincoln et al., 2012).
Multiple paths and subcircuits within BG have been identified. In
some cases the different circuits perform different functions; for
instance the striatum, the input nucleus of the BG, has anatomic
and functional subdivisions including sensorimotor and associa-
tive. In other cases, pathwaysmay compete, as has been postulated
for action selection.
Two of the most studied pathways through the BG are
the direct and indirect pathways, segregated pathways through
medium spiny neurons (MSNs) in the striatum. The names
reflect the fact that the direct pathway proceeds from the stria-
tum directly to either the internal portion of the globus pallidus
(GPi) or the Substantia Nigra pars reticulata (SNr), the two out-
put nuclei of the BG. The indirect pathway, on the other hand,
also involves a subcircuit that includes the external portion of
the globus pallidus (GPe) and the subthalamic nucleus (STN)
before reaching the output nuclei. The two pathways have oppos-
ing effects on the thalamus: the indirect pathway has an inhibitory
effect, while the direct pathway has an excitatory effect (Smith
et al., 1998; Gerfen and Surmeier, 2011).
Albin and DeLong (Albin et al., 1989; DeLong, 1990) pro-
posed that the balance of these opposing pathways is important
for healthy function. Dopaminergic cells in the SNc project to
the striatum and inhibit MSNs in the indirect pathway and excite
MSNs in the direct pathway. Albin and DeLong noted that, dur-
ing PD, the loss of dopaminergic cells in the SNc has the effect
of shifting the balance in favor of the indirect pathway, and they
reasoned that the increased inhibitory output from BG to tha-
lamus might account for some of the motor symptoms of PD,
such as bradykinesia and difficulty in initiating movement. This
view later lost favor in the face of new experimental observations
that appeared to contradict the Albin–DeLong theory. The fact
that pallidotomy—lesioning the GPi—alleviates some PD motor
symptoms fit well with the theory, but it emerged that high fre-
quency stimulation of GPi was equally effective therapeutically.
The solution to this conundrum seemed to be that the pattern of
neuronal firing in the BG was as important for symptoms as the
rate of firing; it was then often assumed that the Albin–DeLong
theory was dead. In particular, it has been established experi-
mentally that firing patterns in the GPi become bursty as PD
progresses. Noting that this firing pattern is effectively a stronger
signal than the irregular firing observed in the healthy GPi, how-
ever, allows the possibility that the Albin-DeLong theory retains
merit but the notion of “balance” needs to be interpreted more
generally. With this more general notion of balance, it is again
widely hypothesized that many of the motor symptoms of PD
are due to an imbalance between the direct and indirect path-
ways (Kravitz et al., 2010; Gerfen and Surmeier, 2011; Zold et al.,
2012).
The BG play a critical role in action selection, and it has
been proposed that changes in DA levels are important in this
process. One key difference between MSNs in the direct and
indirect pathways lies in their responses to extracellular DA:
MSNs in the direct pathway express D1 receptors and are stim-
ulated by DA while MSNs in the indirect pathway express D2
receptors and are inhibited by DA. It is known that D1 recep-
tors mediate the effect of DA on the dyskinesias mentioned
above (Darmopil et al., 2009; Mela et al., 2012). MSNs in both
pathways receive feedforward inhibition from cortical pyrami-
dal neurons that project to striatal inhibitory interneurons; this
inhibition, together with collateral inhibition from other MSNs,
may suppress MSN activity in circuits corresponding to unde-
sired actions. In the circuit of the desired action, selection could
depend upon the level of DA. While both the direct and indi-
rect pathways receive the feed forward inhibition, it has been
found that these inhibitory projections preferentially connect
with the direct pathway and that there is an inhibitory feed-
back loop from the GPe in the indirect pathway (Bevan et al.,
1998; Gerfen and Surmeier, 2011). Since the indirect path-
way MSNs express D2 receptors, this feedback loop is expected
to be inhibited by basal levels of DA. However, a transient
decrease in DA could facilitate the feedback by disinhibiting the
inhibitory projection to the GPe. Meanwhile, cortical excitation
in the direct pathway helps counter the feed forward inhibi-
tion there. In this description of action selection, the presence
of DA helps shift the balance in favor of the direct pathway.
We mention these details of feedforward and feedback circuits
in action selection to show how important the balance between
direct and indirect pathways is in considering action selection,
but these detailed feedforward and feedback circuits are not in
our model.
Computational models of the BG abound, including biophys-
ical models (Terman et al., 2002; Rubchinsky et al., 2003). Many
studies focus on functions believed to be performed by the BG
(Doya, 1999) such as reinforcement learning (Bar-Gad et al.,
2011) or action selection (Gurney et al., 2001; Humphries et al.,
2006; Houk et al., 2007; Girard et al., 2008). These models often
involve competition between different loops through the BG.
Some models explicitly consider the balance between pathways,
with a loss of balance hypothesized to occur when DA is depleted
(Leblois et al., 2006). Contreras-Vidal and Stelmach (1995) also
consider the role of other neuropeptides (dynorphin, Substance P,
enkephalin) in the imbalance of pathways that accompanies nigral
degeneration. However, these studies do not consider the BG to be
embedded in a larger regulatory circuit. Our model uses a simple
global circuit as a platform for investigating the role of serotonin
in the striatum.
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A HYPOTHESIS ABOUT THE ROLE OF 5-HT IN THE STRIATUM
What is the role of 5-HT in the striatum? Both the discussion of
PD and the discussion of action selection above suggest that the
balance between the direct and indirect pathways is important for
the function of the BG in healthy individuals. We will explain how
5-HT in the striatum may help to maintain that balance.
The circuit we will consider is shown schematically in Figure 1.
Dopaminergic neurons in the SNc innervate the MSNs in the
striatum, inhibiting the MSNs in the indirect pathway and stim-
ulating the MSNs in the direct pathway. The DRN sends dense
serotonergic projections to the striatum (Vertes, 1991) and it is
known that increased concentrations of 5-HT in the striatum
facilitate the release of DA from the dopaminergic projections
from the SNc (Blandina et al., 1989; Bonhomme et al., 1995;
Deurwaerdere et al., 1996). Projections from the thalamus excite
cortical neurons. There are numerous projections from higher
brain regions to the DRN (Monti, 2010); in particular there
are inhibitory projections from medial prefrontal cortex (mPFC)
(Celada et al., 2001). In addition, SNc projections excite DRN
neurons (DiMatteo et al., 2008) and DRN neurons inhibit SNc
neurons (Guiard et al., 2008). Nucleus X stands for some other
nucleus that sends excitatory or inhibitory projections to the
DRN. This is the basic structure of our model that is indicated
schematically in Figure 1; many of the details of the direct and
indirect pathways, described in Smith et al. (1998), have been
omitted here.
FIGURE 1 | The influence of the DRN on the direct and indirect
pathways. Dopaminergic neurons of the SNc inhibit the indirect pathway
and stimulate the direct pathway from the cortex to the thalamus.
Serotonin from the DRN projections to the striatum increase DA release
and projections from the cortex inhibit DRN firing. The details of basal
ganglia BG circuitry in the direct and indirect pathways is omitted.
References for the influences are given in the text. There are many
descending projections to the DRN; nucleus X represents one of these that
may excite or inhibit the DRN.
We can now describe verbally how the circuit in Figure 1
allows the serotonergic projection from the DRN to the stria-
tum to maintain the balance between the direct and indirect
pathways. Suppose, for some reason, that the firing of the DA
neurons in the SNc goes down. This will lower DA in the stria-
tum, which in turn will decrease the firing in the direct pathway
and increase the firing in the indirect pathway. Therefore, the tha-
lamus will be more inhibited and the ascending projections to the
mPFC will fire less. Thus, the descending projections from the
mPFC to the DRN will fire less, thus removing inhibition from
the DRN. The increased firing of the DRN neurons will release
more 5-HT in the striatum. Finally, the increased 5-HT tone
in the striatum increases DA release in response to each action
potential, thus partially compensating for the initial decreased DA
release.
METHODS
In this section we describe the details of the mathematical
model that implements the circuit indicated schematically in
Figure 1. The variables of the mathematical model, given in
Table 1, are the firing rates (in Hz) corresponding to the nuclei
pictured in Figure 1 and the concentrations (in nM) of DA
and 5-HT in the striatum. The firing rates can be thought
of as average firing rates in the nuclei or as the firing rates
of particular neurons in the nuclei that correspond to specific
actions.
The differential equations satisfied by the variables are given
below. They are the simplest equations one can imagine that
express the positive and negative influences between the variables
shown in Figure 1. There are external input terms. The influences
are all simple linear functions of the relevant variables except for
the term G · (5HT) · (SN) that expresses the release of DA in the
striatum as function of SNc firing rate and of 5-HT concentra-
tion in the striatum. Most of the equations have decay terms that
guarantee that firing or concentrations go to zero in the absence
of input. Of course, the real physiological situation is much more
complicated. We have left out important nuclei in the BG and
there is no representation of the important dynamics within var-
ious nuclei. The purpose of this simple model is merely to allow
us to investigate and illustrate the hypothesis about the role of
Table 1 | Variables.
Name Steady state Explanation
MI 1.88 Firing rate of striatal spiny neuron in the
indirect pathway (Hz)
MD 1.85 Firing rate of striatal spiny neuron in the direct
pathway (Hz)
TH 17.5 Firing rate of thalamic neuron (Hz)
CX 26.3 Firing rate of cortical neuron (Hz)
DRN 1.41 Firing rate of dorsal raphe nucleus neuron (Hz)
DA 2.72 Concentration of dopamine in the striatum (nM)
5HT 0.846 Concentration of serotonin in the striatum (nM)
SN 4.47 Firing rate of substantia nigra pars compacta
neuron (Hz)
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5-HT in maintaining homeostasis between the direct and indirect
pathways.
dMI
dt
= a1c − a1da · DA− d1 ·MI (1)
dMD
dt
= a2c + a2da · DA− d2 ·MD (2)
d TH
dt
= a3 + a3md ·MD− a3mi ·MI − d3 · TH (3)
d CX
dt
= a4th · TH − d4 · CX (4)
dDRN
dt
= a5 − a5cx · CX + a5sn · SN − d5 · DRN (5)
d DA
dt
= G · 5HT · SN − d6 · DA (6)
d 5HT
dt
= a7 · DRN − d7 · 5HT (7)
d SN
dt
= a8 − a8drn · DRN − d8 · SN (8)
The values of the parameters in the differential equations and
their meanings are listed in Table 2.
The values of the parameters were adjusted so that the steady
state values of the variables are in ranges that correspond to exper-
imental observations. For example, the steady state concentration
of DA in the striatum is 2.72 nM (Segovia and DelArco, 1997;
Jones et al., 1998), the steady state concentration of 5-HT in the
striatum is 0.846 nM (Knobelman et al., 2001), the DRN firing
rate is 1.41Hz (Feldman et al., 1997), the SNc firing rate is 4.47Hz
(Feldman et al., 1997), the firing rates in the indirect and direct
pathways are 1.9Hz (Mahon et al., 2006), and the thalamic fir-
ing rate is 17.5Hz (Ohara et al., 2007). We have not been specific
about which cortical region is projecting to the DRN in ourmodel
so we didn’t make an effort to put that rate in any particular
range.
RESULTS
In this section we describe some experiments with the model that
illustrate and confirm some of the speculations discussed in the
Introduction. We will see that the circuit in Figure 1 automati-
cally compensates for changes in the system that would unbalance
the direct and indirect pathways. The firing rates discussed can be
interpreted as average firing rates of populations of neurons or as
firing rates of individual neurons.
DECREASE IN SNc FIRING
Suppose that the average firing rate of SNc cells decreases, for
example by cell death as in Parkinson’s disease. We can simu-
late this condition by raising the parameter d8 from 10 to 17
because this will lower SNc firing at steady state. If we do this,
the new steady state values of the variables are given in column
A1 of Table 3. The units are Hz except for DA and 5-HT where
the units are nM. These new steady state values are to be com-
pared with the baseline steady states given in the column labeled
Table 2 | Parameters.
Name Value Meaning
a1c 2.333 Cortical input to medium spiny neurons in indirect
pathway
a1da 0.167 Influence of DA on medium spiny neurons in indirect
pathway
d1 1 Decay constant of medium spiny neurons in indirect
pathway
a2c 1.167 Cortical input to medium spiny neurons in direct
pathway
a2da 0.250 Influence of DA on medium spiny neurons in direct
pathway
d2 1 Decay constant of medium spiny neurons in indirect
pathway
a3 1.667 External drive to thalamus
a3md 3.5 Excitation of direct pathway on the thalamus
a3mi 2 Inhibition of indirect pathway on the thalamus
d3 0.25 Decay constant of thalamic neurons
a4th 1.5 Influence of thalamus on cortex
d4 1 Decay constant of cortical neurons
a5 6.667 External drive to the DRN
a5sn 0.01 Excitatory influence of the SNc on the DRN
a5cx 0.175 Inhibition of the DRN neurons by the cortex
d5 1.5 Decay constant of DRN neurons
G 0.72 The influence per nM 5-HT on DA release in the
striatum
d6 1 Decay constant of DA in the striatum
a7 1.2 Influence of DRN firing on 5-HT release in the striatum
d7 2 Decay constant of 5-HT in the striatum
a8 58.833 External drive of the SNc
a8drn 10 Inhibition of SNc neurons by the DRN
d8 10 Decay constant of SNc neurons
“normal” in Table 3. As one can see, the SNc firing rate falls
49% but DA concentration in the striatum falls from 2.72 to
1.98 a decrease of only 27%. The indirect pathway increases by
only 6.6% and the direct pathway decreases by only 10%. This
is the homeostatic effect of the DRN projection to the striatum
discussed above, and it is easy to understand using Figure 1. As
SNc firing decreases, the indirect pathway is more stimulated and
the direct pathway is less stimulated. Thus, the thalamus is more
inhibited and fires less, so the cortex is less stimulated and fires
less. This removes some cortical inhibition from the DRN which
fires more, driving the concentration of 5-HT up in the striatum.
The enhanced 5-HT concentration in the striatum causes more
DA release, which partially compensates for the lower SNc firing
rate.
To test whether these homeostatic effects really are the result of
the circuit in Figure 1, we ran the same simulation as in A1, but
now we kept the 5-HT in the gain term [the first term on the right
side of equation (6)] constant at its normal value of 0.846 nM.
Thus, we have kept the circuit intact but the increase of 5HT in
the striatum will not be felt by the DA terminals. The results are
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Table 3 | Results of simulations no. 1.
Name Normal A1 A2 B C
MI 1.88 2.00 2.145 2.04 2.04
MD 1.85 1.66 1.448 1.66 1.61
TH 17.5 13.93 9.772 12.84 12.84
CX 26.3 20.90 14.66 19.26 19.26
DRN 1.41 2.02 2.75 2.22 2.20
DA 2.72 1.98 1.124 1.76 1.76
5HT 0.846 1.213 1.648 1.33 0.667
SN 4.47 2.271 1.845 3.66 3.66
shown in column A2. Now, MI increases by 14%, MD decreases
by 22% and DA in the striatum decreases by 54%.
DECREASE IN THE GAIN G
Suppose that the gain, G, that governs how much each nM of
5-HT in the striatum increases DA release is cut in half. One
could imagine that half the 5-HT receptors on DA terminals in
the striatum become ineffective. The new steady state values are
are given in column B of Table 3. MI increases by only 7.5% and
MD decreases by only 13%. The reason is that as the direct and
indirect pathways start to become unbalanced the thalamus fires
less and thus the cortex fires less. Thus, the corical inhibition is
partially withdrawn and the DRN fires a lot more (up 58%) and
this causes a 58% rise in striatal 5-HT that partially compensates
for the drop in G. This is true despite the fact that the SNc firing
rate declines because of inhibition from the DRN.
DECREASE IN 5-HT RELEASE
Suppose that we decrease by 50% the coefficient a7, which repre-
sents the amount of 5-HT released per DRN spike in the striatum.
The new steady states are given in column C of Table 3. Although
one might expect that 5-HT would decrease by 50% in the stria-
tum, in fact it only decreases by 21%. The reason, as above, is
that as the direct and indirect pathways become unbalanced, the
thalamus and cortex fire less, so the inhibition of the DRN is
partially withdrawn and DRN firing rises 58%, which partially
compensates for the drop in the 5-HT release coefficient a7. As
a result, the indirect and direct pathways change by only 7.5
and 15%.
THE EFFECTS OF SSRIs
The mechanisms by which chronic doses of selective serotonin
reuptake inhibitors (SSRIs) relieve depressive symptoms in some
patients remain largely unknown. Since many proposed mech-
anisms involve increases in extracellular 5-HT in projection
regions of the raphe nuclei, it was of interest to ask what changes
in the circuit in Figure 1 would result from an increase in
5-HT in the striatum. If we decrease the coefficient d7 in equa-
tion (7) then we expect that the steady state value of 5-HT in
the striatum would increase, so we decreased d7 from 2 to 1.
The results can be seen in column D of Table 4. The firing
rates in the direct and indirect pathways change modestly. But
the most dramatic effect is on the firing of the DRN which
decreases by 44%. As a result, the concentration of 5-HT only
Table 4 | Results of simulations no. 2.
Name Normal D E F1 F2
MI 1.88 1.745 1.749 1.71 2.14
MD 1.85 2.033 2.041 2.1 1.46
TH 17.5 21.1 21.24 22.36 10.02
CX 26.3 31.64 31.86 33.54 15.03
DRN 1.41 0.787 0.795 2.78 0.51
DA 2.72 3.47 3.496 3.73 1.17
5HT 0.846 0.944 0.477 1.67 0.30
SN 4.47 5.096 10.176 3.11 5.38
increases from 0.846 to 0.944 nM. It is known that acute doses
of SSRIs decrease DRN firing (Gartside et al., 1995; Hajos et al.,
1995; ElMansari et al., 2005), so the circuit in Figure 1 gives
a another mechanism by which that could occur. Of course,
the standard mechanism is that by increasing the extrcellular
concentration of 5-HT near the cell bodies in the DRN, the
5-HT1A auto receptors are stimulated and this decreases DRN
firing.
DEEP BRAIN STIMULATION OF THE SNc
Since deep brain stimulation is used to treat a variety of neu-
rological disorders, we asked how stimulation of the SNc would
affect the circuit in the model. To do this we lowered the con-
stant d8 from 10 to 5 which should increase SNc firing. The
results can be seen in column E of Table 4; indeed the firing
rate of the SNc more than doubles. More interesting is the fact
than the firing rate of the DRN decreases by 44% because of
the extra excitation of the direct pathway and the extra inhibi-
tion of the in direct pathway. It is tempting to wonder whether
this is the cause of the the transient acute depression seen
in some patients when the SNc is stimulated (Bejjani et al.,
1999).
The simulations in A–E show how the network in Figure 1
automatically compensates for “flaws” in the DA and 5-HT sys-
tems to try to keep the direct and indirect pathways in balance.
Of course, there may be times when it is important to change the
balance between the pathways.
CHANGING THE BALANCE BETWEEN THE DIRECT AND
INDIRECT PATHWAYS
The role of 5-HT in increasing DA release and the circuit in
Figure 1 can also be used to unbalance the direct and indi-
rect pathways. Suppose that there is some other nucleus (called
nucleus X in Figure 1) that projects to the DRN. The projec-
tion may be excitatory or inhibitory, which would correspond to
increasing or decreasing the external drive, a5, to the DRN. If a5
is increased by 50%, the new steady states are as given in column
F1 of Table 4. So, the indirect pathway has been decreased by 9%
and the direct pathway has been increased by 14%.
Conversely, if we decrease a5 by 50% the new steady states are
as given in column F2 of Table 4. We see that the indirect pathway
is increased by 14% and the direct pathway is decreased by 21%.
Thus, the brain can control the balance between the direct and
indirect pathways via projections to the DRN.
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PHASIC CORTICAL INPUT TO THE DIRECT PATHWAY
Suppose that there is a burst of cortical input to the direct path-
way such as might occur when a particular action is selected and a
particular group of striatal neurons in the direct pathway is stimu-
lated. Now we are thinking of Figure 1 as the connection diagram
for small groups of neurons in each nucleus that correspond to
this action. To test the result in the model we double the cortical
input, a2, to the direct pathway for one second between t = 1 s
and t = 2 s. The result can be seen in Figure 2.
There is a substantial increase in firing in the direct pathway
that decays in about 4 s. Notice that this is followed by several
seconds in which the direct pathway is inhibited and the indi-
rect pathway is increased. This is a result of the feedback pathway
via the DRN depicted in Figure 1. It is tempting to speculate that
this inhibition may play a functional role in action-selection by
turning off the direct pathway after it has been stimulated.
DISCUSSION
The purpose of the simple model in this paper is to illustrate
and investigate various homeostatic mechanisms arising from the
DRN projections to the BG. It is clear that the model is highly
simplified and that many important physiological details have
not been considered. This paper is based on the fact that direct
pathway MSNs express D1 receptors and are stimulated by DA,
while MSNs in the indirect pathway express D2 receptors and are
inhibited by DA. There are other sub-circuits of the BG, such as
the hyperdirect loop (Leblois et al., 2006), and there are other
important serotonergic projections to the BG such as the moder-
ately dense projection from the DRN to the globus pallidus. There
are also other interactions between 5-HT and DA in the BG that
we have not discussed here. Boureau and Dayan (2011) discuss
the opponency between DA and 5-HT in behavior. Dopamine is
important for changes in synaptic strength in the cortical striatal
pathway (Gerfen and Surmeier, 2011). Further, there are differ-
ences between the direct and indirect pathways other than the
FIGURE 2 | Phasic cortical input to the direct pathway. The cortical input
to the direct pathway, a2, was doubled between t = 1 s and t = 2 s. The red
and blue curves show the firing rates as a function of time in the direct and
indirect pathways, respectively.
different dopamine receptor types. For example, indirect pathway
MSNs are more excitable, an effect thought to be due to differ-
ences in morphology (Gerfen and Surmeier, 2011). It is known in
animal models that there is rapid hyper-innervation of the stria-
tum by 5-HT terminals after SNc lesions Maeda et al. (2003).
This would increase the gain, G, in our model and also provide
homeostasis of extracellular DA.
It is not surprising that the BG, a regulatory biochemical and
electrophysiological network of enormous importance for many
aspects of human behavior, would have many built-in homeo-
static mechanisms. Such mechanisms buffer the functions of the
BG in the face of normal biological variations in the parts and also
help to keep the BG functional in the face of large environmen-
tally caused perturbations such as drug use and cell death. One of
the most important such homeostatic mechanisms is the “passive
stabilization” of DA in the striatum after cell death in the SNc. It is
well known that the tissue content of DA in the striatum declines
more or less proportionally to cell death in the SNc (Bezard et al.,
2001; Dentresangle et al., 2001; Bergstrom and Garris, 2003), but
that the extracellular level of DA in the striatum remains almost
constant until 80 or 90% of the cells of the SNc have died. Many
active compensatory mechanisms were proposed, see for example
Hornykiewicz (1966), to explain this remarkable homeostasis.
However, a very simple explanation was proposed in Bergstrom
and Garris (2003). As SNc cells die, less DA is released into the
striatum but there are also proportionally fewer dopamine reup-
take transporters, so the concentration in the extracellular space
should remain constant. This proposal by Bergstrom and Garris
was verified by the current authors using mathematical modeling
in Reed et al. (2009), where it is also explained why the home-
ostasis breaks down when more than 80% of the SNc cells have
died.
In this paper we show how the circuitry in Figure 1 automat-
ically leads to several other homeostatic mechanisms. In Results
A we showed that in the face of decreased SNc cell firing the level
of 5-HT in the striatum will go up and increase the release of DA
per action potential, partially compensating for the loss of SNc
cell firing. Thus the circuit tends to keep the balance between
the direct and indirect pathways. We note that this is consistent
with the finding that the DRN fires more in animal models of
PD (Zhang et al., 2007; Kaya et al., 2008; Wang et al., 2009). In
Results B we showed that if the gain that measures the influence
of 5-HT on DA release decreases (for example by receptor loss),
then the circuit automatically partially compensates by increasing
the firing rate of DRN neurons and thus releasing more 5-HT. In
Results C we showed that if there is a drop in 5-HT release in the
striatum, the circuit will automatically compensate by increasing
DRN firing. All of these effects depend, of course, on the descend-
ing inhibitory projections from the cortex to the DRN, which in
our model we assume are coming from the mPFC (Celada et al.,
2001). So, these results give a reason for the descending inhibitory
projections from the cortex to the DRN.
We also show (Results D) that increasing 5-HT in the stria-
tum, as caused by an SSRI for example, would depress firing in
the DRN. And, similarly, deep brain stimulation of the SNcwould
also depress DRN firing (Results E) and may explain the transient
depression seen in some DBS patients.
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There are times when it might be important to overcome one
of these homeostatic mechanisms, for example by changing the
balance between the direct and indirect pathways for a subset of
neurons involved in choosing a particular action. We showed in
Results F how this can be done by changing the input to the DRN,
in our example by excitatory or inhibitory input from a hypoth-
esized nucleus X. It is tempting to think that this gives a possible
explanation of the plethora of descending projections to the DRN
(Monti, 2010).
Our intention was to use our simple model to discuss possible
roles of 5-HT in the striatum. Though our results are sugges-
tive, the model depends on the circuitry that we hypothesize in
Figure 1. And, therefore, firm conclusions depend on experimen-
tal confirmation.
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